RESISTANCE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT GP120(SF2) TO CHALLENGE BY HIV-1(SF2)

被引:52
作者
ELAMAD, Z
MURTHY, KK
HIGGINS, K
COBB, EK
HAIGWOOD, NL
LEVY, JA
STEIMER, KS
机构
[1] CHIRON BIOCINE,EMERYVILLE,CA 94608
[2] SW FDN BIOMED RES,DEPT VIROL & IMMUNOL,SAN ANTONIO,TX
[3] UNIV CALIF SAN FRANCISCO,SCH MED,CANC RES INST,SAN FRANCISCO,CA 94143
[4] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,SAN FRANCISCO,CA 94143
关键词
HIV-1; VACCINE; RECOMBINANT GP120; PRIMATE; ANIMAL MODELS; ANTIBODIES; ENVELOPE PROTEINS; NEUTRALIZATION; CHIMPANZEE;
D O I
10.1097/00002030-199512000-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine whether vaccination with recombinant HIV-1(SF2) gp120 in a novel oil-in-water adjuvant emulsion, MF59, protects chimpanzees against challenge with HIV-1(SF2), the homologous virus isolate. Methods: Two vaccinated chimpanzees and two control animals were challenged with 25-50 animal infectious doses of a stock of HIV-1(SF2) that had been grown in mitogen-activated human peripheral blood mononuclear cells (PBMC). The animals were monitored by a series of serologic [enzyme-linked immunosorbent assay (ELISA), Western blot, and neutralization assays] and virologic [virus culture, RNA and DNA polymerase chain reaction (PCR)] assays for infection. Results: Both control animals showed evidence of seroconversion in ELISA and Western blot assays. In addition, virus was detected in the early, acute phase of infection of both control animals by (1) plasma RNA PCR, (2) virus culture, and (3) PBMC DNA PCR assays. One vaccinated animal showed no serologic or virologic evidence of infection. The other vaccinated animal has not seroconverted, and there was no evidence of plasma viremia. However, virus was detected at early timepoints in this animal's PBMC, and transient lymphoproliferation to HIV-1 proteins not in the vaccine was observed. These observations suggest that the former animal was protected from challenge while the latter may have experienced a transient or curtailed infection. Conclusion: Two types of vaccine-induced protective immune responses were observed when chimpanzees immunized with rgp120(SF2) were challenged with the homologous virus isolate: a response consistent with the 'sterilizing immune response' documented in the chimpanzee model in previous studies, as well as one that did not completely protect from infection, showing curtailment of the acute phase and a failure of the animal to seroconvert.
引用
收藏
页码:1313 / 1322
页数:10
相关论文
共 30 条
[1]   CHALLENGE OF CHIMPANZEES (PAN-TROGLODYTES) IMMUNIZED WITH HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN-GP120 [J].
ARTHUR, LO ;
BESS, JW ;
WATERS, DJ ;
PYLE, SW ;
KELLIHER, JC ;
NARA, PL ;
KROHN, K ;
ROBEY, WG ;
LANGLOIS, AJ ;
GALLO, RC ;
FISCHINGER, PJ .
JOURNAL OF VIROLOGY, 1989, 63 (12) :5046-5053
[2]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 CHALLENGE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT ENVELOPE GLYCOPROTEIN GP120 [J].
BERMAN, PW ;
GROOPMAN, JE ;
GREGORY, T ;
CLAPHAM, PR ;
WEISS, RA ;
FERRIANI, R ;
RIDDLE, L ;
SHIMASAKI, C ;
LUCAS, C ;
LASKY, LA ;
EICHBERG, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5200-5204
[3]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[4]   EFFECT OF INTRON-A FROM HUMAN CYTOMEGALOVIRUS (TOWNE) IMMEDIATE-EARLY GENE ON HETEROLOGOUS EXPRESSION IN MAMMALIAN-CELLS [J].
CHAPMAN, BS ;
THAYER, RM ;
VINCENT, KA ;
HAIGWOOD, NL .
NUCLEIC ACIDS RESEARCH, 1991, 19 (14) :3979-3986
[5]  
CONRAD AJ, IN PRESS J ACQUIR IM
[6]   PREVENTION OF HIV-1 INFECTION IN CHIMPANZEES BY GP120 V3 DOMAIN-SPECIFIC MONOCLONAL-ANTIBODY [J].
EMINI, EA ;
SCHLEIF, WA ;
NUNBERG, JH ;
CONLEY, AJ ;
EDA, Y ;
TOKIYOSHI, S ;
PUTNEY, SD ;
MATSUSHITA, S ;
COBB, KE ;
JETT, CM ;
EICHBERG, JW ;
MURTHY, KK .
NATURE, 1992, 355 (6362) :728-730
[7]   IMPORTANCE OF HYPERVARIABLE REGIONS OF HIV-1 GP120 IN THE GENERATION OF VIRUS NEUTRALIZING ANTIBODIES [J].
HAIGWOOD, NL ;
SHUSTER, JR ;
MOORE, GK ;
LEE, H ;
SKILES, PV ;
HIGGINS, KW ;
BARR, PJ ;
GEORGENASCIMENTO, C ;
STEIMER, KS .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (07) :855-869
[8]   NATIVE BUT NOT DENATURED RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GENERATES BROAD-SPECTRUM NEUTRALIZING ANTIBODIES IN BABOONS [J].
HAIGWOOD, NL ;
NARA, PL ;
BROOKS, E ;
VANNEST, GA ;
OTT, G ;
HIGGINS, KW ;
DUNLOP, N ;
SCANDELLA, CJ ;
EICHBERG, JW ;
STEIMER, KS .
JOURNAL OF VIROLOGY, 1992, 66 (01) :172-182
[9]   IMPEDIMENTS, IMPONDERABLES AND ALTERNATIVES IN THE ATTEMPT TO DEVELOP AN EFFECTIVE VACCINE AGAINST AIDS [J].
HILLEMAN, MR .
VACCINE, 1992, 10 (14) :1053-1058
[10]   EFFECT OF IMMUNIZATION WITH A VACCINIA-HIV ENV RECOMBINANT ON HIV-INFECTION OF CHIMPANZEES [J].
HU, SL ;
FULTZ, PN ;
MCCLURE, HM ;
EICHBERG, JW ;
THOMAS, EK ;
ZARLING, J ;
SINGHAL, MC ;
KOSOWSKI, SG ;
SWENSON, RB ;
ANDERSON, DC ;
TODARO, G .
NATURE, 1987, 328 (6132) :721-723